LECO opens new separation science facility
LECO has opened a new separation science R&D facility in St. Joseph, Michigan, USA, the Elizabeth S. Warren Technical Centre.
LECO has opened a new separation science R&D facility in St. Joseph, Michigan, USA, the Elizabeth S. Warren Technical Centre.
Named after the LECO Executive Vice President and Treasurer Elizabeth S. Warren, the 28,000 square-foot facility is dedicated to the research and development of instrumentation and equipment for LECO’s separation science product line.
The building features laboratory and office areas and an auditorium for presentations and educational forums. Next door is LECO’s main R&D facility, which shares several engineering and technical groups with the new building.
The new building also creates more space in the adjacent Carl E. Schultz Technical Centre for Research and Development. By moving Separation Science R&D to its own building, the existing technical centre now has more room to focus on the continued development of products for LECO’s inorganic, organic and metallographic product lines. The added space in both buildings will enable a more efficient engineering process from start to finish.
For more information please visit ref="http://www.leco.com">www.leco.com
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
